Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
Logo Image
|Articles|March 4, 2010

BioClinica Partners With Health Sciences International and PRL Central Laboratory Services

BioClinica™, Inc., (NASDAQ: BIOC), a global provider of clinical trial management services, today announced it has created strategic partnerships with two clinical research organizations (CROs), Health Sciences International, Inc., and PRL Central Laboratory Services. Both alliances strengthen the BioClinica Certified Partner Program, a group of VIP CRO partners chosen based on therapeutic expertise and customer satisfaction.
 
“We are proud to partner with Health Sciences International and PRL Central Laboratory Services, expanding upon the dozens of CRO partnerships held by BioClinica worldwide,” said Mark Weinstein, CEO of BioClinica, Inc. “Our newest partners demonstrate the quality and continued growth of the BioClinica Certified Partner Program.  
 
Connecticut-based Health Sciences International, Inc. focuses on conducting phase I-IV trial research with key therapeutic areas of focus including cardiology, vascular disorders, CNS, endocrinology and internal medicine.
 
PRL Central Laboratory Services specializes in comprehensive diagnostic testing, focusing on protocol requirements.  

Related to this article

View more
Where AI Leads in Trial Design—and Where Humans Still Need To
Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.
Read more